GE Notes – Lynch Syndrome

Genomic Notes for Clinicians

Page contents:

https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/lynch-syndrome/

Lynch Syndrome

Key Points

  •  Lynch syndrome is a rare, inherited condition that increases your risk of developing bowel cancer and sometimes other cancers. 
  • Lynch Syndrome accounts for about 3% of all bowel cancer.  
  • Regular bowel screening by colonoscopy can prevent bowel cancers developing.  
  • Bowel Screening usually starts from the age of 25 years and is performed on a yearly basis.  
  • People with Lynch Syndrome are also at increased risk of developing certain other cancers such as uterine (womb), urinary tract, ovary and small bowel.  
  • Women should consider screening of the uterus and ovaries from the age of 30-35 years.  
  • Genetic testing is available for families with this syndrome.  
  • When you have Lynch Syndrome, each of your children have a 1 in 2 (50%) chance of inheriting it.  

https://www.nzfgcs.co.nz/Syndromes/Lynch-Syndrome

Mainstreaming genetics and genomics – Is it Possible in Ireland?

Genetic and genomic health information increasingly informs routine clinical care and treatment.

Building the capacity of the current and next generation of nurses and physicians to integrate genetics and genomics into usual clinical practice is essential if opportunities afforded by precision medicine are to be fully realised.

https://www.gimjournal.org/article/S1098-3600(21)01181-3/fulltext

Acquired vs. Inherited Mutations in Cancer: What You Need to Know 

An example of an inherited risk of cancer is Lynch syndrome. A person with Lynch syndrome has an elevated risk of colorectal, endometrial, stomach, ovarian, urinary tract, other intestinal cancers, and additional cancers.

The increased risk is due to a mutation in one of several genes that fix mistakes made when DNA is copied. These genes are called DNA mismatch repair genes. The body has many mechanisms that work hard to prevent DNA copying errors and protect against cancer.

When one of those mechanisms is disabled by mutations, cancer is more likely to occur and at a younger age.

Bowel Cancer Awareness Month

Very powerful sharing from Roberta. I think Genetic Counsellors everywhere will feel humbled that your experience was empowering & led to the correct diagnosis.

Highlights how important their role is, how families should know their cancer history & have the correct screening.

Is Colon Cancer Risk Hiding in Your Genes?

Most people diagnosed with colorectal cancer are at least 65 years old, but I was only 45 when doctors discovered my cancer, which they believed had been growing inside me for at least a decade. As someone who exercises regularly and maintains a healthy diet, I was shocked by my diagnosis. My doctors and I assumed that it was simply a case of bad luck.

“as many as 10% of colorectal cancer patients have an inherited gene mutation that caused their illness. I should know, because I was one of them.”

“I’ve heard people say that they don’t want to get genetic testing because there’s no way to prevent hereditary cancer, therefore it’s better not to know. But that couldn’t be further from the truth.”

https://www.sfgate.com/sponsoredarticles/lifestyle/health-wellness/article/is-colon-cancer-risk-hiding-in-your-genes-17816195.php

Lynch Syndrome: Know your risk | Dana-Farber Cancer Institute


Dana-Farber’s Matt Yurgelun, MD, discusses Lynch Syndrome research and the challenges of a Lynch Syndrome diagnosis. Dana-Farber’s Lynch Syndrome Center offers genetic testing to help identify Lynch Syndrome carriers who may be at increased risk for a variety of cancers.

2023: A new start for genetic and genomic medicine in Ireland?

According to the HSE’s website, there is “room for improvement” in the medical genetics and genomics services offered in Ireland when compared to other European countries. (perhaps an understatement???)

The strategy states: “To date, Ireland has made some progress in developing its genetic and genomic services, with pockets of excellence evident throughout the country. However, to fully realise the benefits of genetics and genomics, there is an urgent need to mainstream them so that they can become an integral part of our routine care delivery.

Strategies are very helpful in healthcare because a strategy gives you a sense of direction….

Provided for under this strategy is:

  • the creation of a new national office for genetics and genomics
  • the transition of genetics and genomics into routine care delivery
  • targeted workforce planning and development
  • ensuring Public and Patient Involvement (PPI) and partnership
  • the strengthening of Ireland’s infrastructure to drive advances in this area.

On the impact of the national office, Dr Henry predicted there will be a high level of activity “in year one, and the office will drive it”. He said it will “become the engine of what happens in year two, three, four, and later”.

Also, the office will “advocate” and “compete for funding each year”.

As our understanding of disease evolves, it is very clear that genomics will inform much of the decision-making